| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/25/2008 | US20080234192 Compositions and methods of use for treating cardiovascular disease |
| 09/25/2008 | US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue |
| 09/25/2008 | US20080234190 Administering a glial growth factor protein to treat nervous system conditions associated with demyelination, especially of Schwann cells; multiple sclerosis |
| 09/25/2008 | US20080234188 Antimicrobial Peptides |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |
| 09/25/2008 | US20080234186 Synthetic, for the enhancement of fertility, egg production and/or spermatogenesis |
| 09/25/2008 | US20080234184 These membrane domains are of viral envelope proteins that allow viruses to anchor to the target cells that they will infect; allows coexpression of the TME1 and TME2 membrane domains of the hepatitis C virus envelope proteins |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080234181 Antisense Epidermal Growth Factor Receptor/oligonucleotides in which guanidinium residue substitution (N-(2-aminoethyl) D-arginine) is distributed throughout the oligonucleotide; excellent uptake into mammalian cells; resists nucleases and proteases both outside and inside the cell(s) |
| 09/25/2008 | US20080234177 Targeting-enhanced activation of galectins |
| 09/25/2008 | US20080234176 Modified peptides and their uses |
| 09/25/2008 | US20080234175 Reaction mixture of a complex of an negative-sense NS1 protein of influenza virus, or a douple stranded (ds)RNA binding fragment of it, and a dsRNA that binds the protein; targets for drug design; small scale and/or high-throughput screening for inhibitors of interactions between NS1A or NS1B, and dsRNA, |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233645 Methods and Compositions of Ig20 and Denn-Sv Splice Variants |
| 09/25/2008 | US20080233641 Nucleotide sequences coding zinc finger proteins which control genes associated with tocopherol biosynthesis; bioreactors; foods and antioxidants |
| 09/25/2008 | US20080233639 Fusion protein delivery system and uses thereof |
| 09/25/2008 | US20080233638 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233599 Immunogenic glycopeptides, screening, preparation and uses |
| 09/25/2008 | US20080233598 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/25/2008 | US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 09/25/2008 | US20080233595 Method for diagnosing intertility |
| 09/25/2008 | US20080233569 Detection of Extracellular Tumor-Associated Nucleic Acid in Blood Plasma or Serum Using Nucleic Acid Amplification Assays |
| 09/25/2008 | US20080233568 Detection of tumors in blood plasma and hybridization of oncogenes or amplification of nucleic acids for mutant DNA; Extraction; use in identifying, diagnosing, monitoring, or evaluating cancer; gel electrophoresis, hybridization, blot analysis, liquid chromatography; monoclonal antibody cancer therapy |
| 09/25/2008 | US20080233565 PKHDL1, a homolog of the autosomal recessive kidney disease gene |
| 09/25/2008 | US20080233560 DNA-transfection system for the generation of infectious influenza virus |
| 09/25/2008 | US20080233558 Inhibitors of viral entry screening method |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233154 Immunoprotective and nontoxic Gram-negative bleb vaccine suitable for paediatric use; Neisseria meningitides; H. influenzae |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233141 Chimera of papillomavirus capsid polypeptide L2; cervical cancers and warts; capsomeres |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233138 Coccidiosis Poultry Vaccine |
| 09/25/2008 | US20080233137 Block the inflammatory and immunomodulatory activity mediated by endogenous C5a; Adult Respiratory Distress Syndrome (ARDS), severe tissue damage following thrombotic events such as heart attacks and stroke, inflammatory bowel diseases and rheumatoid arthritis |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233123 Polypeptide from haemophilus influenzae |
| 09/25/2008 | US20080233115 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233111 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection |
| 09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2008 | US20080233107 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide |
| 09/25/2008 | US20080233084 providing a protected immobilised Interleukin-8; coupling hydrazinonicotinic acid to immobilised Interleukin-8; deprotecting the HYNIC-conjugated Interleukin-8; cleavage of deprotected HYNIC-conjugated Interleukin-8 from a solid support |
| 09/25/2008 | US20080233083 Methods and Compositions for Vaccination of Animals with Prrsv Antigens with Improved Immunogenicity |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | CA2684578A1 Chimeric antigens |
| 09/25/2008 | CA2684569A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | CA2682112A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | CA2681522A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | CA2681415A1 Mutant g-protein coupled receptors and methods for selecting them |
| 09/25/2008 | CA2681035A1 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
| 09/25/2008 | CA2679686A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 09/25/2008 | CA2672131A1 Potent and selective mediators of cholesterol efflux |
| 09/24/2008 | EP1972935A1 Screening method for infectious agent of prion disease |
| 09/24/2008 | EP1972690A1 Desaturase antigen of mycobacterium tuberculosis |
| 09/24/2008 | EP1972689A2 A mutated immunoglobulin-binding protein |
| 09/24/2008 | EP1972635A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 09/24/2008 | EP1972349A1 GLP-1 fusion peptides conjugated to polymer(s), their production and use |
| 09/24/2008 | EP1972348A1 Novel vaccine composition for the treatment of respiratory infectious diseases |
| 09/24/2008 | EP1972194A1 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 09/24/2008 | EP1971689A2 Gene promoters that can be used in plants |
| 09/24/2008 | EP1971684A1 Chimaeric fusion protein with superior chaperone and folding activities |
| 09/24/2008 | EP1971619A2 Nogo-b receptor |
| 09/24/2008 | EP1971428A2 Production of chiral materials using crystallization inhibitors |
| 09/24/2008 | EP1971367A2 Methods and compositions for needleless delivery of binding partners |
| 09/24/2008 | EP1814378A4 Casein kinase stress-related polypeptides and methods of use in plants |
| 09/24/2008 | EP1725687A4 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides |
| 09/24/2008 | EP1721162B1 Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a |
| 09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
| 09/24/2008 | EP1521771B1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 09/24/2008 | EP1485483B1 Proteolysis resistant active vegf |
| 09/24/2008 | EP1368476B1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/24/2008 | EP1352068B1 Bacillus thuringiensis insecticidal proteins |
| 09/24/2008 | EP1261705B1 Methods and compositions for screening using diphtheria toxin constructs |
| 09/24/2008 | EP1163211B1 Method for acylating peptides and proteins |
| 09/24/2008 | EP1084239B1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| 09/24/2008 | EP1029046B1 Wnt-1 inducible genes |
| 09/24/2008 | EP0979272B1 Strl33, a human fusion accessory factor associated with hiv infection |
| 09/24/2008 | CN101273134A Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes |
| 09/24/2008 | CN101273132A Compositions and methods for treating breast cancer |
| 09/24/2008 | CN101273129A Recombinant vector capable of increasing secretion of koji mold protease |
| 09/24/2008 | CN101273128A Platelet aggregation inhibitor composition |
| 09/24/2008 | CN101273060A Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (PLAD) of tumor necrosis factor receptors |
| 09/24/2008 | CN101273059A Alpha-MSH analogue of therapeutic activity |
| 09/24/2008 | CN101273058A GLP-1 ( glucagon-like peptide-1 ) fusion polypeptides with increased peptidase resistance |
| 09/24/2008 | CN101273057A Bone morphogenesis protein 2 active peptide and production method and application |
| 09/24/2008 | CN101273056A Psma peptide analogues |
| 09/24/2008 | CN101273055A Novel method for preventing or treating m tuberculosis infection |
| 09/24/2008 | CN101273054A An L-amino acid-producing bacterium and a method for producing an L-amino acid |
| 09/24/2008 | CN101273053A IL-6 binding proteins |
| 09/24/2008 | CN101272802A Antibodies to myostatin |
| 09/24/2008 | CN101270360A XAGE-1 gene and application of its expression production in tumour treatment and diagnosis |
| 09/24/2008 | CN101270359A Method for preparing recombined human amyloid A beta 42 and application thereof |
| 09/24/2008 | CN101270159A Antineoplastic cytotoxin of snake venom and preparing technique thereof |
| 09/24/2008 | CN101270158A Target glioma resistant protein, preparation method and application |
| 09/24/2008 | CN101270157A Genetic engineering target glioma Acp-W1 resistant protein, preparation method and application |
| 09/24/2008 | CN101270156A Mutation saccharomyces cerevisiae hansen initiation transcription factor,encoding gene and application thereof |
| 09/24/2008 | CN101270155A Method for assembling foot and mouth disease virus hollow capsid in insect with acidproof improvement |
| 09/24/2008 | CN101270148A Preparation for high-purity laver phycoerythrin with one-step chromatography |